Patent · US Active

Steviol glycoside transport

US11293043B2 · kind B2 · utility

1Cited by

0References

9Claims

0Family size

Assignee

DSM IP ASSETS B.V. · NL

Inventors

Viktor Marius BOER · Echt, NL
Priscilla Zwartjens · Echt, NL
Eric Van Den Berg · Hoboken, US

Key dates

Filing date	Apr 10, 2020
Grant date	Apr 5, 2022
Priority date	—
Expiry date	Apr 10, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y204/01017
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A recombinant host capable of producing a steviol glycoside which overexpresses a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 35 or SEQ ID NO: 38 or an amino acid sequence having at least about 50% sequence identity to either thereto. A recombinant host capable of producing a steviol glycoside which has been modified, preferably in its genome, to result in a deficiency in the production of a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 35 or SEQ ID NO: 38 or an amino acid sequence having at least about 50% sequence identity to either thereto.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.